Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.
Colnot DR, Roos JC, de Bree R, Wilhelm AJ, Kummer JA, Hanft G, Heider KH, Stehle G, Snow GB, van Dongen GA. Colnot DR, et al. Among authors: stehle g. Cancer Immunol Immunother. 2003 Sep;52(9):576-82. doi: 10.1007/s00262-003-0396-5. Cancer Immunol Immunother. 2003. PMID: 14627130 Free PMC article.
CD44v6: a target for antibody-based cancer therapy.
Heider KH, Kuthan H, Stehle G, Munzert G. Heider KH, et al. Among authors: stehle g. Cancer Immunol Immunother. 2004 Jul;53(7):567-79. doi: 10.1007/s00262-003-0494-4. Epub 2004 Feb 5. Cancer Immunol Immunother. 2004. PMID: 14762695 Free PMC article. Review.
Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
Slobbe P, Windhorst AD, Stigter-van Walsum M, Schuit RC, Smit EF, Niessen HG, Solca F, Stehle G, van Dongen GA, Poot AJ. Slobbe P, et al. Among authors: stehle g. Nucl Med Biol. 2014 Oct;41(9):749-57. doi: 10.1016/j.nucmedbio.2014.06.005. Epub 2014 Jun 25. Nucl Med Biol. 2014. PMID: 25066021
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W. Hartung G, et al. Among authors: stehle g. Clin Cancer Res. 1999 Apr;5(4):753-9. Clin Cancer Res. 1999. PMID: 10213209 Clinical Trial.
67 results